Siren Biotechnology

San Francisco, United States · Founded 2023 · $36.1M raised

Headquarters
San Francisco
Founded
2023
Business Model
B2B
Total Funding
$36.1M
Last Round
$4.0M GrantNov 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

Siren Biotechnology is a San Francisco-based biotech company pioneering Universal AAV Immuno-Gene Therapy for cancer. The company combines two transformative therapeutic technologies — AAV gene therapy and cytokine immunotherapy — into a single modality designed to destroy tumor cells and elicit anti-tumor immunity. Siren's vision is for this therapy to become the standard of care for any solid tumor cancer, with brain cancer as its first therapeutic focus.

Summary

Siren Biotechnology is a Biotech company based in San Francisco, United States, founded in 2023. It has raised $36.1M in total across 3 rounds, most recently a $4.0M Grant round in Nov 2023. Investors include California Institute for Regenerative Medicine (CIRM), Founders Fund and Lux Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantNov 2023
$4.0M

Sign up to see all 3 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Siren Biotechnology on Indexed.vc
<a href="https://indexed.vc/companies/siren-biotechnology"><img src="https://indexed.vc/api/badge/company/siren-biotechnology" alt="Siren Biotechnology on Indexed.vc" width="260" height="76" /></a>